Speaker illustration

Doctor Fraz A Ismat

Insmed Incorporated, Bridgewater (United States of America)

Fraz Ismat is trained in Internal Medicine, Paediatrics & Paediatric Cardiology. Following his training in clinical medicine and cardiovascular developmental biology, Dr. Ismat has been working drug development.

Safety, tolerability, and pharmacokinetics (PK) of treprostinil palmitil inhalation powder (TPIP): a phase 1, randomised, double-blind, single- and multiple-dose study

Event: ESC Congress 2021 - The Digital Experience

Topic: Pulmonary Hypertension

Session: Pulmonary arterial hypertension: risk stratification guides for new treatments and informed outcomes


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb